BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
astec lifesciences ltd stock

ASTEC LIFESCIENCES LTD Share Price

1084.85 0.59 (0.05%)
Dec 13 2024 03:29 PM Agro Chemicals NSE: ASTEC

ASTEC LIFESCIENCES LTD Share Price Update

As of the latest trading session, ASTEC LIFESCIENCES LTD share price is currently at 1084.85, which is up by 0.59 from its previous closing. Today, the stock has fluctuated between 1074.05 and 1089.95. Over the past year, ASTEC LIFESCIENCES LTD has achieved a return of -6.73 %. In the last month alone, the return has been 2.06 %. Read More...

ASTEC LIFESCIENCES LTD Performance

Day Range

Low1074.05 High1089.95
1082.05

52 Week Range

Low 825.05 High 1474.40
1082.05

ASTEC LIFESCIENCES LTD Share Price

17728

533138

ASTEC

img img img img
No Data Available

Open Price

1080.00

Prev. Close

1084.25

Volume (Shares)

9834.00

Total traded value

106.40

Upper Circuit

1301.10

Lower Circuit

867.40

Note: The current prices & values are delayed, Login to your account for live updates.

ASTEC LIFESCIENCES LTD Fundamentals


(Standalone)

Market Cap (Cr) 2127.30
PE Ratio (TTM) -20.50
Book Value / Share 148.30
Beta 0.49
ROE -11.93%
EPS (TTM) 0.00
Dividend Yield 0.14%
Net Profit Qtr (Cr) -38.57

ASTEC LIFESCIENCES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 98.55
Operating Expense 139.10
Net Profit -38.57
Net Profit Margin (%) -39.13
Earnings Per Share (EPS) -19.67
EBITDA -17.74
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 69.37
Operating Expense 131.95
Net Profit -39.74
Net Profit Margin (%) -57.28
Earnings Per Share (EPS) -20.26
EBITDA -45.34
Effective Tax Rate (%) 35.56
Particulars MAR 2024 (Values in Cr)
Revenue 153.75
Operating Expense 156.74
Net Profit -0.99
Net Profit Margin (%) -0.64
Earnings Per Share (EPS) -0.50
EBITDA 14.73
Effective Tax Rate (%) -3.12
Particulars DEC 2023 (Values in Cr)
Revenue 50.79
Operating Expense 83.94
Net Profit -24.35
Net Profit Margin (%) -47.94
Earnings Per Share (EPS) -12.42
EBITDA -17.43
Effective Tax Rate (%) 24.49
Particulars SEP 2023 (Values in Cr)
Revenue 110.79
Operating Expense 129.38
Net Profit -13.45
Net Profit Margin (%) -12.14
Earnings Per Share (EPS) -6.86
EBITDA -2.47
Effective Tax Rate (%) 23.75
Particulars MAR 2024 (Values in Cr)
Revenue 458.18
Operating Expense 525.64
Net Profit -46.99
Net Profit Margin (%) -10.25
Earnings Per Share (EPS) -23.96
EBITDA -0.32
Effective Tax Rate (%) 24.06
Particulars MAR 2023 (Values in Cr)
Revenue 628.17
Operating Expense 606.35
Net Profit 25.52
Net Profit Margin (%) 4.06
Earnings Per Share (EPS) 13.02
EBITDA 89.30
Effective Tax Rate (%) 26.77
Particulars MAR 2022 (Values in Cr)
Revenue 676.57
Operating Expense 565.99
Net Profit 89.82
Net Profit Margin (%) 13.27
Earnings Per Share (EPS) 45.85
EBITDA 164.55
Effective Tax Rate (%) 25.79
Particulars MAR 2021 (Values in Cr)
Revenue 554.87
Operating Expense 473.87
Net Profit 64.69
Net Profit Margin (%) 11.65
Earnings Per Share (EPS) 33.05
EBITDA 119.17
Effective Tax Rate (%) 27.04
Particulars MAR 2020 (Values in Cr)
Revenue 522.22
Operating Expense 472.88
Net Profit 47.47
Net Profit Margin (%) 9.09
Earnings Per Share (EPS) 24.27
EBITDA 97.13
Effective Tax Rate (%) 22.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 188.32
ROE % -11.89
ROCE % -4.49
Total Debt to Total Equity 1.06
EBITDA Margin -0.06
Particulars MAR 2023 (Values in Cr)
Book Value / Share 213.90
ROE % 6.27
ROCE % 7.73
Total Debt to Total Equity 0.76
EBITDA Margin 14.22
Particulars MAR 2022 (Values in Cr)
Book Value / Share 202.32
ROE % 25.47
ROCE % 22.17
Total Debt to Total Equity 0.66
EBITDA Margin 24.32
Particulars MAR 2021 (Values in Cr)
Book Value / Share 157.84
ROE % 23.42
ROCE % 22.27
Total Debt to Total Equity 0.51
EBITDA Margin 21.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 126.00
ROE % 21.17
ROCE % 20.43
Total Debt to Total Equity 0.61
EBITDA Margin 18.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 188.01
ROE % -11.93
ROCE % -4.50
Total Debt to Total Equity 1.06
EBITDA Margin -0.07
Particulars MAR 2023 (Values in Cr)
Book Value / Share 213.61
ROE % 6.26
ROCE % 7.73
Total Debt to Total Equity 0.76
EBITDA Margin 14.22
Particulars MAR 2022 (Values in Cr)
Book Value / Share 202.06
ROE % 25.49
ROCE % 22.17
Total Debt to Total Equity 0.66
EBITDA Margin 24.32
Particulars MAR 2021 (Values in Cr)
Book Value / Share 157.60
ROE % 23.31
ROCE % 22.18
Total Debt to Total Equity 0.52
EBITDA Margin 21.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 125.94
ROE % 21.15
ROCE % 20.41
Total Debt to Total Equity 0.61
EBITDA Margin 18.60
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.43
Total Assets 974.92
Total Liabilities 974.92
Total Equity 369.51
Share Outstanding 19609205
Price to Book Ratio 5.65
Return on Assets (%) -4.81
Return on Capital (%) -5.44
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.15
Total Assets 979.41
Total Liabilities 979.41
Total Equity 419.55
Share Outstanding 19605660
Price to Book Ratio 6.47
Return on Assets (%) 2.61
Return on Capital (%) 3.36
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.12
Total Assets 896.75
Total Liabilities 896.75
Total Equity 396.65
Share Outstanding 19597555
Price to Book Ratio 8.67
Return on Assets (%) 10.02
Return on Capital (%) 13.29
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.57
Total Assets 677.58
Total Liabilities 677.58
Total Equity 309.31
Share Outstanding 19587555
Price to Book Ratio 6.35
Return on Assets (%) 9.60
Return on Capital (%) 13.1
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.48
Total Assets 571.71
Total Liabilities 571.71
Total Equity 246.89
Share Outstanding 19568355
Price to Book Ratio 3.18
Return on Assets (%) 8.31
Return on Capital (%) 13.75
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.39
Total Assets 974.14
Total Liabilities 974.14
Total Equity 368.67
Share Outstanding 19609205
Price to Book Ratio 5.65
Return on Assets (%) -4.82
Return on Capital (%) -5.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.37
Total Assets 978.84
Total Liabilities 978.84
Total Equity 418.79
Share Outstanding 19605660
Price to Book Ratio 6.47
Return on Assets (%) 2.60
Return on Capital (%) 3.36
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.81
Total Assets 896.70
Total Liabilities 896.70
Total Equity 395.98
Share Outstanding 19597555
Price to Book Ratio 8.67
Return on Assets (%) 10.01
Return on Capital (%) 13.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.56
Total Assets 677.89
Total Liabilities 677.89
Total Equity 308.70
Share Outstanding 19587555
Price to Book Ratio 6.35
Return on Assets (%) 9.54
Return on Capital (%) 13.05
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.45
Total Assets 572.09
Total Liabilities 572.09
Total Equity 246.43
Share Outstanding 19568355
Price to Book Ratio 3.18
Return on Assets (%) 8.29
Return on Capital (%) 13.75
Particulars MAR 2024 (Values in Cr)
Net Income -61.74
Cash from Operations 12.18
Cash from Investing -135.18
Cash from Financing 124.95
Net change in Cash 0.00
Free Cash Flow 147.68
Particulars MAR 2023 (Values in Cr)
Net Income 34.94
Cash from Operations 79.54
Cash from Investing -112.50
Cash from Financing 37.77
Net change in Cash -0.08
Free Cash Flow 196.80
Particulars MAR 2022 (Values in Cr)
Net Income 121.12
Cash from Operations 52.75
Cash from Investing -103.86
Cash from Financing 80.47
Net change in Cash 0.21
Free Cash Flow 156.73
Particulars MAR 2021 (Values in Cr)
Net Income 89.07
Cash from Operations 14.84
Cash from Investing -73.10
Cash from Financing 81.33
Net change in Cash 0.06
Free Cash Flow 117.37
Particulars MAR 2020 (Values in Cr)
Net Income 61.35
Cash from Operations 186.65
Cash from Investing -73.81
Cash from Financing -94.53
Net change in Cash 0.09
Free Cash Flow 231.95
Particulars MAR 2024 (Values in Cr)
Net Income -61.87
Cash from Operations 12.05
Cash from Investing -134.97
Cash from Financing 124.85
Net change in Cash 0.00
Free Cash Flow 147.55
Particulars MAR 2023 (Values in Cr)
Net Income 34.84
Cash from Operations 79.18
Cash from Investing -112.07
Cash from Financing 37.66
Net change in Cash -0.08
Free Cash Flow 196.44
Particulars MAR 2022 (Values in Cr)
Net Income 121.04
Cash from Operations 52.53
Cash from Investing -103.56
Cash from Financing 80.36
Net change in Cash 0.21
Free Cash Flow 156.51
Particulars MAR 2021 (Values in Cr)
Net Income 88.67
Cash from Operations 14.92
Cash from Investing -73.10
Cash from Financing 81.22
Net change in Cash 0.05
Free Cash Flow 117.45
Particulars MAR 2020 (Values in Cr)
Net Income 61.27
Cash from Operations 186.76
Cash from Investing -73.81
Cash from Financing -94.64
Net change in Cash 0.10
Free Cash Flow 232.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
EXCEL INDUSTRIES LTD 1375.65 22.74 1.08 1729.29 698.90 / 1745.00
PUNJAB CHEM & CROP PROT L 1075.00 33.44 3.74 1317.95 900.50 / 1575.00
DHANUKA AGRITECH LTD 1621.35 27.29 5.81 7389.84 940.90 / 1926.40
UPL LIMITED 549.80 0.00 1.53 46426.96 429.71 / 599.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
BAYER CROPSCIENCE LTD 6252.80 48.48 9.11 28101.39 4868.70 / 7189.90
EXCEL INDUSTRIES LTD 1375.65 22.79 1.38 1729.29 698.90 / 1745.00
PUNJAB CHEM & CROP PROT L 1075.00 32.41 3.55 1317.95 900.50 / 1575.00
RALLIS INDIA LTD 310.95 40.59 3.14 6047.01 233.05 / 378.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1085.90
  • 26 Days 1076.50
  • 10 Days 1083.40
  • 50 Days 1092.20
  • 12 Days 1081.50
  • 100 Days 1138.30
  • 20 Days 1075.90
  • 200 Days 957.80
1088.10
PIVOT
First Resistance 1095.10
Second Resistance 1105.95
Third Resistance 1112.95
First Support 1077.25
Second Support 1070.25
Third Support 1059.40
RSI 50.79
MACD 5.01
Commodity Channel Index (CCI) 43.89
ADX 16.16
Williams % R -48.31

Over 1 Month

down

2.06

Over 3 Months

down

-10.62

Over 6 Months

down

-12.18

Over 1 Year

down

-6.73

Over 3 Years

down

-11.35

Over 5 Years

down

22.11

ASTEC LIFESCIENCES LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ASTEC LIFESCIENCES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
28.21
Promoter Holdings
66.74
FII
0.53
DII
4.5
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Godrej Agrovet Limited Shareholding of Promoter and Promoter Group 1.2699054E7 64.75
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund Public Shareholding 468589.0 2.39
Ashok Vishwanath Hiremath Shareholding of Promoter and Promoter Group 390802.0 1.99
Shreans Daga Public Shareholding 331349.0 1.69
Kaushik Daga Public Shareholding 295287.0 1.51
Chitralekha Ashok Hiremath Shareholding of Promoter and Promoter Group 0.0 0.0

ASTEC LIFESCIENCES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-21 1.5 Final 2023-07-22 Equity shares 2022-07-19 1.5 Final 2022-07-21 Equity shares 2021-07-22 1.5 Final 2021-07-24 Equity shares 2020-07-16 1.5 Final 2020-07-18 Equity shares 2019-07-18 1.5 Final 2019-07-22 Equity shares 2018-07-19 1.5 Final 2018-07-23 Equity shares 2017-07-17 1.5 Final 2017-07-19 Equity shares 2015-09-15 1.25 Final 2015-09-18 Equity shares 2014-09-15 1.0 Final 2014-09-17 Equity shares 2013-09-02 0.75 Final 2013-09-04 Equity shares 2012-09-13 0.5 Final 2012-09-17 Equity shares 2011-09-15 0.5 Final 2011-09-19 Equity shares 2010-08-12 1.0 Final 2010-08-16 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ASTEC LIFESCIENCES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ASTEC LIFESCIENCES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Astec Lifesciences Ltd?

Answer Field

The share price of Astec Lifesciences Ltd for NSE is ₹ 1084.85 and for BSE is ₹ 1085.

What is the Market Cap of Astec Lifesciences Ltd?

Answer Field

The market cap of Astec Lifesciences Ltd for NSE is ₹ 21,27.30 Cr. and for BSE is ₹ 21,27.59 Cr. as of now.

What is the 52 Week High and Low of Astec Lifesciences Ltd?

Answer Field

The 52 Week High and Low of Astec Lifesciences Ltd for NSE is ₹ 1474.40 and ₹ 825.05 and for BSE is ₹ 1487.65 and ₹ 826.15.

How to Buy Astec Lifesciences Ltd share?

Answer Field

You can trade in Astec Lifesciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Astec Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been -6.73%.

What is the Current Share Price of Astec Lifesciences Ltd?

Answer Field

Astec Lifesciences Ltd share price is for NSE ₹ 1084.85 & for BSE ₹ 1085 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Astec Lifesciences Ltd Share?

Answer Field

The market cap of Astec Lifesciences Ltd for NSE ₹ 21,27.30 & for BSE ₹ 21,27.59 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Astec Lifesciences Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Astec Lifesciences Ltd share is -20.50.

What is the PB ratio of Astec Lifesciences Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Astec Lifesciences Ltd share is 148.30.

How to Buy Astec Lifesciences Ltd Share?

Answer Field

You can trade in Astec Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Astec Lifesciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Astec Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Astec Lifesciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader